statements

Medinova Diagnostic Services Ltd.

BSE: 526301

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

43.45-0.6 (-1.27%)

24 Nov, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Medinova Diagnostic Services Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	TTM Sep 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	TTM Sep 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	12.96	12.46	11.08	7.69	8.06	7.79	8.67	8.97	7.45	12.74	13.20	9.99	10.17	9.81	9.98
Cost of Operating Revenue	2.18	2.12	2.05	1.79	2.82	3.79	3.23	2.61	2.04	2.30	3.09	1.62	1.13	0.79	0.70
Gross Profit	10.78	10.35	9.03	5.90	5.24	4.00	5.44	6.36	5.41	10.44	10.11	8.37	9.04	9.03	9.28
Gross Margin	83.2	83.0	81.5	76.7	65.0	51.4	62.8	70.9	72.6	81.9	76.6	83.8	88.9	92.0	93.0
Total Operating Expenses	13.16	12.62	12.04	12.33	10.04	10.34	9.82	8.92	7.20	10.45	10.04	7.72	7.51	6.96	6.65
Operating Profit	-0.20	-0.16	-0.97	-4.63	-1.97	-2.55	-1.15	0.05	0.24	2.29	3.16	2.27	2.65	2.85	3.33
Operating Margin	-1.5	-1.3	-8.7	-60.2	-24.5	-32.8	-13.3	0.5	3.3	18.0	23.9	22.8	26.1	29.1	33.4
Financing Income/(Expense) - Net	-0.09	-0.07	-0.10	-0.06	-0.50	-1.06	-0.84	-0.66	-0.59	-0.46	-0.51	-0.60	-0.54	-0.41	-0.47
Profit before Taxes	-0.27	-0.27	0.30	-4.21	-2.29	-1.84	-0.52	1.09	-0.28	1.96	2.80	1.90	2.28	2.50	3.05
Income Taxes	-0.01	-0.02	0.31	-0.62	-0.22	-0.10	-0.06	0.27	-0.05	0.06	0.42	0.23	0.28	0.60	0.90
Profit after Tax	-0.26	-0.24	-0.02	-3.59	-1.90	-1.39	-0.14	0.81	-0.26	2.02	2.27	1.67	2.00	1.90	2.15
PAT Margin	-2.0	-2.0	-0.2	-46.7	-23.6	-17.8	-1.6	9.1	-3.5	15.9	17.2	16.7	19.7	19.3	21.6
EPS - Basic - ex Extraordinary Items	-0.28	-0.26	-0.02	-3.79	-2.01	-1.39	-0.14	0.81	-0.26	2.03	2.27	1.67	2.00	1.90	2.15
EPS - Diluted - ex Extraordinary Items	-0.28	-0.26	-0.02	-3.79	-2.01	-1.39	-0.14	0.81	-0.26	2.03	2.27	1.67	2.00	1.90	2.15
EBIT	-0.20	-0.16	-0.97	-4.63	-1.97	-2.55	-1.15	0.05	0.24	2.29	3.16	2.27	2.65	2.85	3.33
EBITDA	0.38	0.43	-0.39	-3.60	-0.06	0.11	0.73	1.33	1.20	3.01	3.71	2.60	2.78	3.00	3.48
EBITDA Margin	3.0	3.5	-3.5	-46.8	-0.7	1.4	8.4	14.9	16.0	23.6	28.1	26.0	27.4	30.5	34.8

Balance Sheet

Abridged

Understanding Balance Sheet

Medinova Diagnostic Services Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	4.92	4.40	2.72	2.76	2.33	1.27	1.24	1.04	1.11	1.55	2.07	1.69	2.60	4.21
Long-Term Investments	-	-	-	0.88	0.44	0.29	0.15	0.14	0.14	-	0.14	0.55	0.55	0.30
Property Plant & Equipment - Net	6.55	5.88	4.28	1.07	9.40	6.89	4.48	3.33	2.40	1.87	1.48	1.54	1.60	1.91
Total Non-Current Assets	18.67	18.03	4.36	2.49	9.96	7.32	4.84	3.74	2.95	2.82	2.37	2.79	2.78	2.72
Total Assets	23.59	22.43	7.09	5.25	12.29	8.59	6.08	4.77	4.06	4.37	4.44	4.48	5.38	6.93
Total Current Liabilities	10.10	8.97	9.49	10.39	13.42	10.91	9.94	9.37	8.78	7.95	5.20	3.59	3.28	2.98
Long Term Debt	16.07	16.28	0.24	1.36	7.49	6.81	5.44	3.91	4.03	3.27	5.75	5.75	5.00	5.00
Total Non-Current Liabilities	16.42	16.63	0.79	1.63	7.93	7.25	6.08	4.53	4.64	3.93	6.05	6.02	5.22	5.20
Total Liabilities	26.52	25.60	10.28	12.03	21.35	18.15	16.02	13.90	13.42	11.88	11.25	9.61	8.51	8.18
Total Shareholders' Equity	-2.93	-3.17	-3.19	-6.78	-9.16	-9.56	-9.71	-8.91	-9.17	-7.20	-6.81	-5.14	-3.12	-1.25
Minority Interest	-	-	-	-	0.09	-	-0.23	-0.22	-0.19	-0.31	-	-	-	-
Total Equity	-2.93	-3.17	-3.19	-6.78	-9.07	-9.56	-9.94	-9.13	-9.36	-7.50	-6.81	-5.14	-3.12	-1.25
Total Liabilities & Equity	23.59	22.43	7.09	5.25	12.29	8.59	6.08	4.77	4.06	4.37	4.44	4.48	5.38	6.93

Cash Flow

Abridged

Understanding Cash Flow Statement

Medinova Diagnostic Services Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.24	0.33	-0.43	-0.71	-0.19	-0.89	0.01	0.76	0.99	2.94	1.25	1.92	2.25	2.17
Working Capital - Increase/(Decrease)	0.10	-0.64	2.05	0.41	-0.74	-0.05	0.37	0.19	-0.03	-1.08	-1.48	-0.68	-0.15	-0.20
Net CF from Operating Activities	0.35	-0.31	1.62	-0.29	-0.93	-0.94	0.38	0.95	0.96	1.86	-0.23	1.25	2.10	1.97
Capital Expenditures - Net	0.97	0.05	-0.70	0.43	4.65	0.11	-0.37	0.15	0.02	0.18	0.16	0.39	0.21	0.48
Net CF from Investing Activities	-0.89	0.07	1.03	-1.30	-4.65	-0.11	0.37	-0.15	-0.02	-0.43	-1.86	-0.39	-0.21	-1.98
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	1.02	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	0.10	0.20	-15.97	1.59	5.76	-0.80	-1.27	-1.05	-1.22	-0.47	-0.56	-0.63	-0.75	-
Net Cash Flow from Financing Activities	0.60	0.20	-2.66	1.59	5.64	1.01	-0.71	-0.85	-0.79	-1.17	1.91	-0.63	-0.75	-
Free Cash Flow to Equity	-0.52	-0.16	-13.64	0.86	0.19	-1.84	-0.52	-0.26	-0.27	1.21	-0.95	0.23	1.14	1.49
Free Operating CF net dividend	-0.69	-0.36	1.43	-0.96	-5.58	-1.25	0.25	0.79	0.94	1.67	-0.39	0.86	1.88	1.46
Free Operating CF	-0.69	-0.36	1.43	-0.96	-5.58	-1.25	0.25	0.79	0.94	1.67	-0.39	0.86	1.88	1.46

Business Segment Analysis

Medinova Diagnostic Services Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Medinova Diagnostic Services Ltd.

Regional Segment Analysis

Medinova Diagnostic Services Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Medinova Diagnostic Services Ltd.

Historical Segment Analysis

Track how Medinova Diagnostic Services Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Medinova Diagnostic Services Ltd.

Frequently Asked Questions

What is the revenue of Medinova Diagnostic Services Ltd.?

The latest trailing twelve month revenue of Medinova Diagnostic Services Ltd. is ₹ 9.98 Cr, reflecting a 1-year growth of 0.49% and a 3-year CAGR of -1.13%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Medinova Diagnostic Services Ltd.?

The latest trailing twelve month net profit (PAT) of Medinova Diagnostic Services Ltd. is ₹ 2.15 Cr, with a 3-year earnings CAGR of 16.29%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Medinova Diagnostic Services Ltd.?

The trailing twelve month EBITDA of Medinova Diagnostic Services Ltd. is approximately ₹ 3.33 Cr (based on an operating margin of 33.39%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Medinova Diagnostic Services Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Medinova Diagnostic Services Ltd. is 2.14. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Medinova Diagnostic Services Ltd.?

The debt-to-equity ratio of Medinova Diagnostic Services Ltd. stands at -. The interest coverage ratio is 7.05x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Medinova Diagnostic Services Ltd.?

The book value per share of Medinova Diagnostic Services Ltd. is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Medinova Diagnostic Services Ltd.?

The trailing twelve month operating cash flow of Medinova Diagnostic Services Ltd. is ₹ 2.97 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Medinova Diagnostic Services Ltd. report consolidated or standalone financials?

Medinova Diagnostic Services Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.